Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Celgene Corporation Has "Optionality and Opportunity"


Celgene Corporation Has "Optionality and Opportunity"

Celgene (NASDAQ: CELG) got crushed after announcing third-quarter earnings, saying revenue would come in at the bottom of previous guidance, and lowering its 2020 guidance. All things considered, though, the biotech isn't in that bad of a shape: It still expects to grow revenue and earnings by double digits over the next three years.

Metric

Q3 2017

Continue reading


Source: Fool.com

Celgene Corp. Stock

€97.58
-0.130%
Celgene Corp. shows a slight decrease today, losing €0.060 (-0.130%) compared to yesterday.

Like: 0
Share

Comments